🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Some experts stated the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Content Removal

Based on TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Digital Trading Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, positive testimonials and detailed guides for preparing or injecting at residence.

After minutes of entering one community, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Information and Costs

Within these groups, messages display black plastic parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has already seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.